Header Logo
  • VIICTR Profiles
  • ORIT
  • Pediatrics CRA
  • Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (5)
    • Antifoaming Agents
    • ELKHANANY, AHMED
    • Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.
    • Scavenger Receptors, Class C
    • Ultrasonics
    • See All 5 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression.

Epigenetic loss of AOX1 expression via EZH2 leads to metabolic deregulations and promotes bladder cancer progression. Oncogene. 2020 10; 39(40):6265-6285.

View in: PubMed

subject areas
  • Aldehyde Oxidase
  • Animals
  • Cell Line, Tumor
  • Disease Progression
  • Enhancer of Zeste Homolog 2 Protein
  • Epigenesis, Genetic
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Kynurenine
  • Male
  • Metabolomics
  • Mice
  • NADP
  • Neoplasm Invasiveness
  • Neoplasm Staging
  • Nucleotides
  • Pentose Phosphate Pathway
  • Tissue Array Analysis
  • Tryptophan
  • Urinary Bladder
  • Urinary Bladder Neoplasms
  • Xenograft Model Antitumor Assays

authors with profiles
  • CRISTIAN COARFA
  • ARUN SREEKUMAR
  • NAGIREDDY PUTLURI
  • HUGO VILLANUEVA